Biosimilars in Canada: what plan sponsors can do. For plan sponsors that want to take advantage of the savings available through biosimilar biologics, several options are available. Since the regulatory environment prohibits automatic interchange with the reference biologic, plan design is very much a driver of success for the selected […]
We will use your email address to send you our newsletter.
All communications will be from TELUS Health.
All fields are required